Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See
full details
.
I Agree
×
Join today and have your say! It’s FREE!
Join Now
Sign In
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.
Join Today
or
Sign in with existing account
Privacy Policy
|
Disclaimer
Sign In
Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Remember me
Forgot Password?
Sign In
or
Sign Up
Privacy Policy
|
Disclaimer
Please Try Again
{{ error }}
Send my password
Submit
Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Linking with Facebook:
Stockhouse membership requires an email address which must be shared by Facebook.
By default, joining or signing in using your Facebook account will work and the email address will be shared by Facebook automatically.
If you change your Facebook permissions to restrict Stockhouse from receiving your email while joining or signing in to Stockhouse then it will fail.
Please do not modify the permission settings during sign-in.
Sign in with Facebook
Return to Signup Options
Home
Community
Bullboards
Blogs
Groups
Messages
Markets
Stocks
TSX
TSXV
CSE
Cboe Canada
NASDAQ
NYSE
NYSE American
Cryptocurrency
Currencies
Market Movers
Bonds
News
Featured News
Trending News
Canadian Press Releases
US Press Releases
Video
Editorial
Thematic Insights
Independent Reports
Interviews
Buzz on the Bullboards
Portfolio
Watchlist
Portfolio
Showcase Companies
DealRoom
Quote
|
Bullboard
|
News
|
Opinion
|
Profile
|
Peers
|
Filings
|
Financials
|
Options
|
Price History
|
Ratios
|
Ownership
|
Insiders
|
Valuation
Bullboard - Stock Discussion Forum
Atara Biotherapeutics Inc
ATRA
Healthcare
Biotechnology
Atara Biotherapeutics, Inc. is an allogeneic T-cell immunotherapy company. The Company is a developer of T-cell immunotherapy, leveraging its novel allogeneic Epstein-Barr virus (EBV) T-cell platform to develop transformative therapies for patients with serious diseases. Its pipeline products include Ebvallo (Tab-cel), ATA3219, and ATA3431. The Company’s T-cell immunotherapy, tab-cel...
(tabelecleucel), is in Phase III development for patients with EBV-driven post-transplant lymphoproliferative disease (EBV+ PTLD) who have failed rituximab or rituximab plus chemotherapy, as well as other EBV-driven diseases. Its ATA3219 allogeneic CD19 CAR T immunotherapy, targeting B-cell malignancies and autoimmune diseases, is based on a next-generation 1XX CAR co-stimulatory domain and EBV T-cell platform and does not require TCR or HLA gene editing. ATA3431 is an allogeneic, bispecific CAR directed against CD19 and CD20 for B-cell malignancies and autoimmune disease.
see more
Join the community and start posting on the bullboards today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Create a portfolio watchlist today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Add To Watchlist
Bullboard (NDAQ:ATRA)
New Post
View:
Posts & Comments
Threaded Posts
(10)
•••
MikeTester
X
Post by
MikeTester
on Jan 24, 2025 9:09am
Atara Biotherapeutics: Pioneering T-cell Immunotherapy for C
Looks like ATRA is making some serious moves in the T-cell immunotherapy space. Ebvallo getting approved in Europe is huge - first allogeneic T-cell therapy on the market. FDA priority review coming
...more
(105)
•••
Iseneschal
X
Post by
Iseneschal
on Sep 05, 2024 12:36pm
ATRA....still moving higher post P.O
Now $10.64 You just never know what those Maggots are up to.....too many tricks up their sleeves They will always win.....you will always lose
(105)
•••
Iseneschal
X
Post by
Iseneschal
on Sep 04, 2024 11:32am
ATRA.....now up over $2/sh
go figure....skating !
(105)
•••
Iseneschal
X
Post by
Iseneschal
on Sep 04, 2024 10:26am
ATRA......P.O NR from yesterdays close....and it's still up?
Atara Biotherapeutics Announces $36 Million Registered Direct Offering 2024-09-03 13:16 ET - News Release Led by Existing Top Institutional Investors With Participation
...more
(105)
•••
Iseneschal
X
Comment by
Iseneschal
on Jul 17, 2024 9:15am
RE:ATRA.....recent RS climbing "The Wall"
Wortha repeat....Hell ya !!!!! $14 HOLLA !!!!! On a NR this a.m!!!! Atara Biotherapeutics Announces U.S. FDA Acceptance and Priority Review of the Biologics License Application for Tabelecleucel
...more
(105)
•••
Iseneschal
X
Comment by
Iseneschal
on Jul 16, 2024 10:58am
RE:ATRA.....recent RS climbing "The Wall"
LoL......FOMO's entering the fray N.H.O.D & H.O.D post RS No selling til over $25
(105)
•••
Iseneschal
X
Post by
Iseneschal
on Jul 16, 2024 10:08am
ATRA.....recent RS climbing "The Wall"
could be "A close shave" currently at $12....a break of previous high would be meaningful....$12.46
(16)
•••
Johnthe6
X
Post by
Johnthe6
on Jun 20, 2024 12:34pm
Atara about to go live!
Atara is going to present at this bio conference, https://2ly.link/1yXNe, don't miss!
(16)
•••
Johnthe6
X
Post by
Johnthe6
on Jun 17, 2024 1:34pm
Atara new virtual event
They said Atara is going to present at this free virtual event! Free register here --> https://buff.ly/4bSLhjm
(16)
•••
Johnthe6
X
Post by
Johnthe6
on Jun 05, 2024 3:12pm
Atara's new presentation
Guys! Atara Bio gonna present at this virtual event! It’s free, go check this out! https://buff.ly/4bSLhjm
(0)
•••
Saaaa1
X
Post by
Saaaa1
on May 06, 2021 8:35pm
$iMIN making moves in Ethereum Crypto !! 🚀🚀🚀🚀🚀
iMining Launches Fractional Staking to Enable Retail Investors to Participate in Ethereum 2.0's Proof-Of-Stake Mining Vancouver, British Columbia - (Newsfile Corp. - April 20, 2021) - iMining
...more
Thank You
Your Report has been submitted.
Report Abusive Content
×
Close
Sign up to get access
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Market Update
{{currentVideo.title}}
{{currentVideo.relativeTime}}
{{previousButtonTitle}}
{{nextButtonTitle}}
A daily snapshot of everything
from market open to close.
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}
{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >